AGILVAX
Agilvax is a private company that discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. The company identifies and selects lead vaccine candidates through its proprietary affinity optimizes those by in vitro and in vivo testing and develops them through pre-clinical and/or clinical testing until proof of concept is achieved establishing attractive out-licensing opportunities to Pharma or Biotech partners. Collaborations and partnerships are actively pursued within the industry, academia, and the government sector through NIAID.
AGILVAX
Industry:
Biotechnology Health Care Medical
Founded:
2011-01-01
Address:
Albuquerque, New Mexico, United States
Country:
United States
Website Url:
http://www.agilvax.com
Total Employee:
11+
Status:
Closed
Contact:
5057974531
Email Addresses:
[email protected]
Total Funding:
9.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Person Schema
Current Advisors List
Current Employees Featured
Founder
Investors List
National Cancer Institute SBIR Development Center
National Cancer Institute SBIR Development Center investment in Grant - Agilvax
National Cancer Research Institute
National Cancer Research Institute investment in Grant - Agilvax
Sun Mountain Capital
Sun Mountain Capital investment in Series A - Agilvax
J. Hunt Holdings
J. Hunt Holdings investment in Series A - Agilvax
J. Hunt Holdings
J. Hunt Holdings investment in Series A - Agilvax
Official Site Inspections
http://www.agilvax.com
- Host name: 104.21.33.39
- IP address: 104.21.33.39
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
